Fisetin has been shown to mitigate renal inflammation and apoptosis, preserving organ function in murine models of septic AKI. This protective effect is achieved through the inhibition of the Src-mediated NF-κB p65 and MAPK signaling pathways. The gene discussed is SRC; the disease is acute kidney injury.